AI confidence 44% · prior close shown (market closed)
Investment Snapshot
Why it matters
THERMO FISHER SCIENTIFIC INC. shows accelerating business momentum based on AlphaOS pipeline evidence, with mixed management execution.
Why it matters: Revenue +10% YoY in Q2 FY2026.
Key signals
What it means for the thesis — synthesis, not a raw event feed.
- Revenue +10% YoY in Q2 FY2026
- Strong Revenue Growth
Pipeline evidence · 0d ago
TMO's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on TMO.
Free accounts see more of this; Premium sees all of it.
Latest earnings · Q2 2026
Full TMO earnings analysisReported figures for THERMO FISHER SCIENTIFIC INC. — research only, not investment advice.
- Revenue YoY
- +10.4%
- EPS YoY
- +9.3%
Latest Intelligence
Updated
What happened recently for THERMO FISHER SCIENTIFIC INC. (TMO) — events, not interpretation.
- Event
- Reported Q2 2026 revenue +10% YoY.
- Also
- Last session September 25, 2026 at $675.
- Source
- Q2 2026 earnings
Research & analysis only — not investment advice.
Loading earnings intelligence…
THERMO FISHER SCIENTIFIC INC. (TMO)
Investment Snapshot above is the primary AlphaOS analysis for THERMO FISHER SCIENTIFIC INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Key facts
- Sector:
- Healthcare
- Industry:
- Diagnostics & Research
- Market cap:
- $249.58B
- Revenue:
- $11.99B
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected intelligence
Follow THERMO FISHER SCIENTIFIC INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
THERMO FISHER SCIENTIFIC INC. (TMO) in AlphaOS research
- theme
Healthcare Innovation: Where the Real Edge Lives
The biggest gains aren't in blockbuster drugs — they're in the infrastructure that makes every drug possible.
- theme
Genomics & Biotech: Precision Medicine Is Reshaping Drug Development
The tools to read, edit, and deliver on the genome are maturing faster than the market prices in.
- theme
Healthcare Innovation: Precision Beats Volume
The edge in healthcare no longer belongs to the biggest drug pipelines — it belongs to the most targeted ones.
- theme
Healthcare Innovation: Where Biology Meets the Next Trillion
Surgical robots, mRNA pipelines, and liquid biopsies are converging—and most investors are still treating them as separate bets.
- theme
Genomics & Biotech: Advancing Precision Medicine
Breakthroughs in gene editing and targeted therapies are reshaping healthcare landscapes.
- theme
Healthcare Innovation Drives New Drugs, Devices, and Digital Care
Breakthroughs in therapies, diagnostics, and digital health are transforming medical outcomes.
Related & Connected
Related stock research
Connected companies and research pages from the AlphaOS knowledge graph.
- DANAHER CORP /DE/ (DHR)Investment Snapshot & knowledge graph →
- Vulcan Materials CO (VMC)Investment Snapshot & knowledge graph →
- CHARTER COMMUNICATIONS, INC. /MO/ (CHTR)Investment Snapshot & knowledge graph →
- HUMANA INC (HUM)Investment Snapshot & knowledge graph →
- Constellation Energy Corp (CEG)Investment Snapshot & knowledge graph →
- Gen Digital Inc. (GEN)Investment Snapshot & knowledge graph →